🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congrats Victor! We’ve been waiting for this, so well deserved.

Great time celebrating Victor Ambrose and his wife/collaborator Candy this morning UMass Chan Medical School! They talked about how unique, special, and friendly our community is at UMass, as well as how much fun it is to do science here. We're having a big party over here!

1/ 🚨 Hot off the press! 🚨Our new paper, led by Andreas Obers & Maximilien Evrard, is now live in Immunity! 🧬 Curious how CD8+ tissue-resident memory T cells (TRM) adopt their fate in different organs? Let’s dive in! 🧵👇 authors.elsevier.com/c/1jw~j_OR~yiO…

Published today! Spatial proteomics reveals JAK/STAT as a target for Toxic Epidermal Necrolysis, an often fatal skin reaction to common medication. We validated our findings in pre-clinical models & successfully treated the first patients worldwide.🧵⬇️ nature.com/articles/s4158…

I had a great time talking to my friends about #vitiligo yesterday in the Dept of Medicine Department of Medicine! It was the first time anyone had written a song about my lecture, you can listen to it here: suno.com/song/dee7ca40-… Thanks Dr. Salomon-Escoto and the entire department!

Update on what causes vitiligo and how that understanding is leading to new treatments: nextstepsinderm.com/derm-topics/la…

Strong work by Mike Frisoli, MD/PhD student in my lab who wanted to dig deeply into mechanisms of skin allergy. Used single cell RNA seq to reveal key signaling pathways that drive disease, as well as biomarkers that distinguish ACD from irritant. nam10.safelinks.protection.outlook.com/?url=https%3A%…

If you have #vitiligo, please consider signing up for our VIGOR study, focused on finding what causes vitiligo. It is for entire families of those who have vitiligo, and can be done from your home! Enrolling 1000 volunteers, a little over halfway there! vigor.umassmed.edu/vigor/s/?langu…

Go Victor!

Vitiligo review is published! Most up to date synthesis on what causes vitiligo and how that is leading to exciting new treatments. We also discuss how vitiligo is an excellent model of autoimmunity for other diseases that are more difficult to study, like T1D, MS, and others.

Meet Dr. Qi Tang, who made the siRNA drug that Alys Pharma will advance into clinic this year. Perfect timing, he gave lab meeting this morning! Currently a postdoctoral fellow with me and anastasia khvorova, but soon to start his own lab in our department. Doing great things!

John E. Harris, MD, PhD'05, remembers matching into an internship at UMass Chan Medical School and a dermatology residency at Penn. He reflects on his #MatchDayMemories and offers advice to the class matching Friday in this video. 📩 #tbt #UMassChanMatch John E. Harris, MD, PhD UMass Chan Department of Dermatology University of Massachusetts

Have you seen the latest #SOCS podcast episode, with Crystal Aguh MD and John E. Harris, MD, PhD? Check out the podcast, by HCPLive and Skin of Color, here: hcplive.com/view/skin-of-c…

Congrats to my friend and colleague Anastasia Khvorova and KhvorovaLab for being awarded the Else Kröner Fresenius Prize for Medical Research! This includes $2.7M to advance siRNA therapy for brain diseases. umassmed.edu/news/news-arch…

This drug was created by our shared postdoc Qi and licensed from UMass by my company Alys Pharma. Excited to see the results in patients with alopecia areata!

Congrats Anastasia Khvorova !